ARS Pharmaceuticals Statistics
Total Valuation
SPRY has a market cap or net worth of $987.50 million. The enterprise value is $873.05 million.
Important Dates
The next estimated earnings date is Thursday, March 19, 2026, before market open.
| Earnings Date | Mar 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRY has 98.85 million shares outstanding. The number of shares has increased by 1.59% in one year.
| Current Share Class | 98.85M |
| Shares Outstanding | 98.85M |
| Shares Change (YoY) | +1.59% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 9.50% |
| Owned by Institutions (%) | 60.65% |
| Float | 52.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.03 |
| Forward PS | 5.96 |
| PB Ratio | 6.84 |
| P/TBV Ratio | 7.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.66, with a Debt / Equity ratio of 1.15.
| Current Ratio | 6.66 |
| Quick Ratio | 6.41 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -45.92% and return on invested capital (ROIC) is -329.76%.
| Return on Equity (ROE) | -45.92% |
| Return on Assets (ROA) | -19.22% |
| Return on Invested Capital (ROIC) | -329.76% |
| Return on Capital Employed (ROCE) | -28.20% |
| Weighted Average Cost of Capital (WACC) | 7.10% |
| Revenue Per Employee | $854,922 |
| Profits Per Employee | -$479,281 |
| Employee Count | 167 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 6.57 |
Taxes
In the past 12 months, SPRY has paid $288,000 in taxes.
| Income Tax | 288,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.24% in the last 52 weeks. The beta is 0.74, so SPRY's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -30.24% |
| 50-Day Moving Average | 10.29 |
| 200-Day Moving Average | 12.61 |
| Relative Strength Index (RSI) | 43.37 |
| Average Volume (20 Days) | 1,798,985 |
Short Selling Information
The latest short interest is 20.22 million, so 20.46% of the outstanding shares have been sold short.
| Short Interest | 20.22M |
| Short Previous Month | 20.51M |
| Short % of Shares Out | 20.46% |
| Short % of Float | 38.38% |
| Short Ratio (days to cover) | 11.35 |
Income Statement
In the last 12 months, SPRY had revenue of $142.77 million and -$80.04 million in losses. Loss per share was -$0.82.
| Revenue | 142.77M |
| Gross Profit | 114.87M |
| Operating Income | -90.79M |
| Pretax Income | -79.75M |
| Net Income | -80.04M |
| EBITDA | -89.81M |
| EBIT | -90.79M |
| Loss Per Share | -$0.82 |
Full Income StatementBalance Sheet
The company has $288.21 million in cash and $169.81 million in debt, with a net cash position of $118.40 million or $1.20 per share.
| Cash & Cash Equivalents | 288.21M |
| Total Debt | 169.81M |
| Net Cash | 118.40M |
| Net Cash Per Share | $1.20 |
| Equity (Book Value) | 147.66M |
| Book Value Per Share | 1.49 |
| Working Capital | 287.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$85.38 million and capital expenditures -$641,000, giving a free cash flow of -$86.02 million.
| Operating Cash Flow | -85.38M |
| Capital Expenditures | -641,000 |
| Free Cash Flow | -86.02M |
| FCF Per Share | -$0.87 |
Full Cash Flow StatementMargins
Gross margin is 80.46%, with operating and profit margins of -63.59% and -56.06%.
| Gross Margin | 80.46% |
| Operating Margin | -63.59% |
| Pretax Margin | -55.86% |
| Profit Margin | -56.06% |
| EBITDA Margin | -62.90% |
| EBIT Margin | -63.59% |
| FCF Margin | n/a |
Dividends & Yields
SPRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.59% |
| Shareholder Yield | -1.59% |
| Earnings Yield | -8.07% |
| FCF Yield | -8.68% |
Analyst Forecast
The average price target for SPRY is $35.00, which is 250.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $35.00 |
| Price Target Difference | 250.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 43.56% |
| EPS Growth Forecast (5Y) | 33.30% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SPRY has an Altman Z-Score of 3.13 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.13 |
| Piotroski F-Score | 2 |
